Bionoid Pharma Inc.
BINP
$0.08
$0.000.00%
OTC PK
| 03/31/2012 | 03/31/2011 | ||||
|---|---|---|---|---|---|
| Net Income | -- | -9.09M | |||
| Total Depreciation and Amortization | -- | 33.00K | |||
| Total Amortization of Deferred Charges | -- | 0.00 | |||
| Total Other Non-Cash Items | -- | 6.62M | |||
| Change in Net Operating Assets | -- | 298.30K | |||
| Cash from Operations | -- | -2.14M | |||
| Capital Expenditure | -- | -7.30K | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | -- | -7.30K | |||
| Total Debt Issued | -- | -9.50K | |||
| Total Debt Repaid | -- | -20.00K | |||
| Issuance of Common Stock | -- | 2.45M | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | -- | 2.42M | |||
| Foreign Exchange rate Adjustments | -- | 14.40K | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -- | 287.90K | |||